Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€86.04

€86.04

0.190%
0.16
0.190%
€114.00

€114.00

 
14:07 / Tradegate WKN: A2PSR2 / Name: BioNTech / Stock / Mid Cap /
Latest predictions
12.03.24
-1.96%
buy
06.03.24
2.65%
buy
14.02.24
1.65%
buy
08.02.24
-1.83%
buy
13.12.23
-2.05%
buy
€200.00
19.11.23
-4.80%
buy
Best running prediction
€130.00
13.10.21
-59.32%
Your prediction

BioNTech SE ADR Stock

The BioNTech SE ADR stock is trending slightly upwards today, with an increase of €0.16 (0.190%) compared to yesterday's price.
With 11 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 114 € shows a positive potential of 32.5% compared to the current price of 86.04 € for BioNTech SE ADR.
For the coming years our community has positive and negative things to say abot the BioNTech SE ADR stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Expected dividend yield" there were negative voices in the community.

Pros and Cons of BioNTech SE ADR in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-17

Upon initial examination, the financial statements of BioNTech, a company operating within the pharmaceutical industry, present a strong financial position. The company has exhibited consistent growth, maintaining robust liquidity, and profitability ratios.

Asset Growth: BioNTech's total assets increased significantly from €2.31 billion in 2020 to €23.28 billion in 2022, showcasing robust growth within just two years. Particularly, current assets, such as cash and receivables, have exhibited remarkable expansion.

Profitability: The company displays impressive net income figures, from €15.2 million in 2020 to a staggering €9.43 billion in 2022. This increase in net income underscores the company's ability to generate substantial profits.

Comments

Prediction Buy
Perf. (%) 3.38%
Target price 170.000
Change
Ends at 17.12.22

Target price set to 170.0
Show more

Buy BioNTech SE ADR
Show more

Buy BioNTech SE ADR
Show more